ICICI Prudential Nifty Pharma Index Fund Direct Growth

ICICI Prudential Nifty Pharma Index Fund Direct Growth

Get the latest NAV of ICICI Prudential Nifty Pharma Index Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹16.69

-0.1%1D

NAV as on 16 May 2025

23.89%/per year

Since Inception

Absolute Gain%

884 people have invested ₹ 43.1L in ICICI Prudential Nifty Pharma Index Fund Direct Growth in the last three months

Peer comparison

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
ICICI Prudential Nifty Pharma Index Fund
-
83Cr
0.37%
13.91%
-
23.89%
HDFC BSE Sensex Index Fund Direct Growth
1/7
8,290Cr
0.2%
12.08%
16.61%
13.3%
UTI Nifty 50 Index Fund Direct Growth
3/17
22,521Cr
0.17%
11.96%
17.11%
13.14%
HDFC Nifty 50 Index Fund Direct Growth
6/17
19,877Cr
0.2%
11.89%
17.08%
13.19%

ICICI Prudential Nifty Pharma Index Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit


Total Corpus

0

Absolute Return

ICICI Prudential Nifty Pharma Index Fund Asset Allocation

See fund asset allocation details as on (13-May-25)

Fund Distribution

as on (13-May-25)

Equity 99.9%

Debt & Cash 0.1%

Large cap
63.4%

Mid cap
28.7%

Small cap
7.8%

Cash allocation has gone down from 0.7% to 0.1%
Cash allocation has gone down from 0.7% to 0.1%

ICICI Prudential Nifty Pharma Index Fund Sector Allocation

See fund sector allocation details as on (13-May-25)

Sector Allocation

Equity 99.9%

Debt & Cash 0.1%

Health
100%

Top Sector in April was Health

Apr'25

Health

100%

Mar'25

Health

100%

ICICI Prudential Nifty Pharma Index Fund Holdings Details

as on (30-Apr-25)

Equity

Holdings
Weight%
1M Change
Sun Pharmaceuticals Industries Ltd
25.51%
0.8%
Cipla Ltd
11.26%
0.9%
Divi's Laboratories Ltd
9.98%
0.9%
Dr Reddy's Laboratories Ltd
9.33%
0.9%
Lupin Ltd
6.54%
0.9%
Top Stocks bought last month
Sun Pharmaceuticals Industries Ltd's allocation increased from 24.74% to 25.51%
Sun Pharmaceuticals Industries Ltd's allocation increased from 24.74% to 25.51%
Cipla Ltd's allocation increased from 10.73% to 11.26%
Cipla Ltd's allocation increased from 10.73% to 11.26%
Divi's Laboratories Ltd's allocation increased from 9.7% to 9.98%
Divi's Laboratories Ltd's allocation increased from 9.7% to 9.98%
Top Stocks sold last month
Dr Reddy's Laboratories Ltd's allocation decreased from 10.1 % to 9.33 %
Dr Reddy's Laboratories Ltd's allocation decreased from 10.1 % to 9.33 %
Mankind Pharma Ltd's allocation decreased from 3.62 % to 3.59 %
Mankind Pharma Ltd's allocation decreased from 3.62 % to 3.59 %
Laurus Labs Ltd's allocation decreased from 3.18 % to 3.05 %
Laurus Labs Ltd's allocation decreased from 3.18 % to 3.05 %

ICICI Prudential Nifty Pharma Index Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio0.37%
Benchmark
Nifty Pharma TR INR
AUM₹83 Cr
Inception Date15 December, 2022
Min Lumpsum/SIP₹1000/₹1000
Exit Load0%
Lock InNo Lock-in
TurnOver
3.54%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About ICICI Prudential Nifty Pharma Index Fund

ICICI Prudential Nifty Pharma Index Fund Direct Growth is an equity fund. This fund was started on 15 December, 2022. The fund is managed by Nishit Patel. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. ICICI Prudential Nifty Pharma Index Fund Direct Growth has ₹83 Cr worth of assets under management (AUM) as on Apr 2025 and is less than category average.
  2. The fund has an expense ratio 0.4.

Returns

ICICI Prudential Nifty Pharma Index Fund Direct Growth has given a CAGR return of 23.89% since inception. Over the last 1 year the fund has given a CAGR return of 13.91%.

Holdings

ICICI Prudential Nifty Pharma Index Fund Direct Growth has allocated its funds majorly in Health, Cash Equivalent. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Divi's Laboratories Ltd, Dr Reddy's Laboratories Ltd, Lupin Ltd

Taxation

As it is a index funds mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of ICICI Prudential Nifty Pharma Index Fund Direct Growth

The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 1000.00 and for SIP is INR 1000.00. ICICI Prudential Nifty Pharma Index Fund Direct Growth has no lock in period.

Fund Manager

Nishit Patel

Fund Manager of ICICI Prudential Nifty Pharma Index Fund Direct Growth, since 15 December 2022

Learn more about ICICI Mutual Fund
Parameters
Apr'25
Mar'25
Feb'25
AUM
₹ 80.6 Cr
₹ 80.6 Cr
₹ 75.1 Cr
  • AUM of the fund stands at 80.6 Cr as of Apr'25
  • AUM has remained same between Apr'25 and Mar'25

Frequently Asked Questions for ICICI Prudential Nifty Pharma Index Fund Direct Growth

What is the current NAV of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

The current NAV of ICICI Prudential Nifty Pharma Index Fund Direct Growth is ₹16.69 as on 16-May-2025.

What are the average returns of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

Existing (Absolute + CAGR) as on 16-May-2025.
ICICI Prudential Nifty Pharma Index Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
3.61%
3.61%
6 Month Returns
-0.42%
-0.42%
1 Year Returns
13.91%
13.91%
3 Years Returns
0%
0%

How do I invest in ICICI Prudential Nifty Pharma Index Fund Direct Growth?

With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.

What is the expense ratio of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

0.37% as on April 2025

What is net assets under management (AUM) of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

₹83 Cr as on April 2025

What are the top 5 holdings of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

Sun Pharmaceuticals Industries Ltd(25.51%), Cipla Ltd(11.26%), Divi's Laboratories Ltd(9.98%), Dr Reddy's Laboratories Ltd(9.33%), Lupin Ltd(6.54%) as on April 2025

What is the alpha of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

The alpha ratio for the ICICI Prudential Nifty Pharma Index Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
ICICI Prudential Nifty Pharma Index Fund Direct Growth
-0.62
-
-
As on April 2025
The alpha for ICICI Prudential Nifty Pharma Index Fund Direct Growth is calculated against Nifty Pharma TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.

What is the beta of ICICI Prudential Nifty Pharma Index Fund Direct Growth??

The Beta ratio for the ICICI Prudential Nifty Pharma Index Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
ICICI Prudential Nifty Pharma Index Fund Direct Growth
1
-
-
As on April 2025
The Beta for ICICI Prudential Nifty Pharma Index Fund Direct Growth is calculated with Nifty Pharma TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.

What is the sharpe ratio of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

The sharpe ratio for the ICICI Prudential Nifty Pharma Index Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
ICICI Prudential Nifty Pharma Index Fund Direct Growth
0.45
-
-
As on April 2025
The sharpe ratio for ICICI Prudential Nifty Pharma Index Fund Direct Growth is calculated with Nifty Pharma TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.

What is the standard deviation of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

The standard deviation for the ICICI Prudential Nifty Pharma Index Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
ICICI Prudential Nifty Pharma Index Fund Direct Growth
20.27
-
-
As on April 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.

Who is the manager of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

Nishit Patel is the fund manager of ICICI Prudential Nifty Pharma Index Fund Direct Growth

What is the exit load of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

The Exit load of ICICI Prudential Nifty Pharma Index Fund Direct Growth is 0%